Advancements in pharmacogenomics, personalized medicine, and innovative drug delivery systems hold promise for improving pediatric drug approval processes. Ongoing efforts to streamline regulatory pathways and increase collaboration among stakeholders will likely enhance the development of safe and effective pediatric medications.
